INHIBITOR THERAPTICS INC INTI

$0.08 +9.61% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-14 View →
4 4 2026-08-04 View →
4 4 2026-08-04 View →
4 4 2026-08-04 View →
4 4 2026-08-04 View →
4 4 2026-08-04 View →
4 4 2026-06-24 View →
4 4 2026-06-01 View →
10-Q 10-Q 2026-05-15 View →
8-K 8-K 2026-04-01 View →
8-K 8-K 2026-04-01 View →
10-K 10-K 2026-03-26 View →
8-K 8-K 2026-02-24 View →
10-Q 10-Q 2025-11-13 View →
8-K 8-K 2025-10-27 View →
10-Q 10-Q 2025-08-13 View →
10-Q 10-Q 2025-05-14 View →
4 Insider transaction 2025-04-10 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
10-K Annual report 2025-03-28 View →
10-Q Quarterly report 2024-11-12 View →
10-Q Quarterly report 2024-08-06 View →
4 Insider transaction 2024-05-16 View →
4 Insider transaction 2024-05-16 View →
4 Insider transaction 2024-05-16 View →
4 Insider transaction 2024-05-16 View →
4 Insider transaction 2024-05-16 View →
10-Q Quarterly report 2024-05-13 View →
10-K Annual report 2024-03-29 View →
8-K FORM 8-K 2023-12-14 View →
10-Q Quarterly report 2023-11-13 View →
8-K 8-K 2023-10-18 View →
4 4 2023-08-29 View →
8-K 8-K 2023-08-29 View →
10-Q Quarterly report 2023-08-11 View →
8-K Current report (material event) 2023-05-31 View →
SC 13D SC 13D 2023-05-23 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.08
Market Cap
52-Week Range
$0.04 $0.12
Average Volume
23K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.